Tarsus Insider PYOTT Grants 5,893 Options & 3,729 RSUs, Betting Big on 2027‑2029 Pipeline Success Amid CEO Sell‑Offs ?
Insider PYOTT DAVID E I’s 2026 option and RSU buy at Tarsus shows long‑term confidence amid CEO sales, signaling potential upside once clinical milestones hit.
3 minutes to read
